                         SEQUENCE LISTING

<110>  BRANDEIS UNIVERSITY
 
<120>  THIOPHOSPHOPEPTIDES FOR ULTRAFAST TARGETING OF THE GOLGI 
       APPARATUS

<130>  147376.000661

<150>  63/148,412
<151>  2021-02-11

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  1

Phe Phe Lys Tyr 
1               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  2

Phe Phe Phe Lys Tyr 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  3

Phe Phe Gly Lys Tyr 
1               5   


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  4

Phe Phe Gly Lys 
1               


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  5

Phe Phe Gly Lys Phe 
1               5   


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 is 2,6-dimethyl-L-tyrosine

<400>  6

Phe Phe Lys Xaa 
1               


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xa at position 5 is 2,6-dimethyl-L-tyrosine

<400>  7

Phe Phe Phe Lys Xaa 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa at position 5 is 2,6-dimethyl-L-tyrosine

<400>  8

Phe Phe Gly Lys Xaa 
1               5   


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  9

Phe Phe Cys Tyr 
1               


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  10

Phe Phe Phe Cys Tyr 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  11

Phe Phe Gly Cys Tyr 
1               5   


<210>  12
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  12

Phe Phe Gly Cys 
1               


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide

<400>  13

Phe Phe Gly Cys Phe 
1               5   


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 is 2,6-dimethyl-L-tyrosine

<400>  14

Phe Phe Cys Xaa 
1               


<210>  15
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa at position 5 is 2,6-dimethyl-L-tyrosine

<400>  15

Phe Phe Phe Cys Xaa 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa at position 5 is 2,6-dimethyl-L-tyrosine

<400>  16

Phe Phe Gly Cys Xaa 
1               5   


